- Report
- September 2024
- 26 Pages
Australia
From €995EUR$1,205USD£891GBP
- Report
- September 2024
- 27 Pages
Canada
From €995EUR$1,205USD£891GBP
From €995EUR$1,205USD£891GBP
- Report
- September 2024
- 28 Pages
United Kingdom
From €995EUR$1,205USD£891GBP
- Report
- September 2024
- 23 Pages
China
From €995EUR$1,205USD£891GBP
- Report
- September 2024
- 25 Pages
Italy
From €995EUR$1,205USD£891GBP
- Report
- September 2024
- 27 Pages
France
From €995EUR$1,205USD£891GBP
- Report
- September 2024
- 231 Pages
China
From €3539EUR$4,000USD£3,060GBP
- Report
- July 2024
- 116 Pages
Global
From €3981EUR$4,500USD£3,443GBP
- Report
- March 2024
- 171 Pages
North America
€4419EUR$4,995USD£3,821GBP
- Report
- February 2024
- 380 Pages
Global
€4419EUR$4,995USD£3,821GBP
- Report
- January 2024
- 227 Pages
Global
€4419EUR$4,995USD£3,821GBP
- Report
- January 2024
- 113 Pages
United States
€3096EUR$3,500USD£2,678GBP
- Report
- June 2023
- 27 Pages
Global
€10837EUR$12,250USD£9,372GBP
- Report
- March 2023
- 30 Pages
Global
€10837EUR$12,250USD£9,372GBP
- Report
- February 2023
- 27 Pages
Global
€10837EUR$12,250USD£9,372GBP
- Report
- October 2022
- 20 Pages
Global
€10837EUR$12,250USD£9,372GBP
- Training
- 90 Minutes
Global
- Report
- December 2022
- 30 Pages
Global
From €1769EUR$2,000USD£1,530GBP
- Report
- November 2022
- 54 Pages
Global
From €1769EUR$2,000USD£1,530GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more